UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030402 |
|---|---|
| Receipt number | R000034712 |
| Scientific Title | Effect of the new surface anesthesia at the time of injection |
| Date of disclosure of the study information | 2018/01/04 |
| Last modified on | 2017/12/14 21:43:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of the new surface anesthesia at the time of injection
Acronym
Effect of the new surface anesthesia
Scientific Title
Effect of the new surface anesthesia at the time of injection
Scientific Title:Acronym
Effect of the new surface anesthesia
Region
| Japan |
Condition
Condition
None
Classification by specialty
| Oral surgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the efficacy of the new surface anesthesia at
the time of injection
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The reduced level of the pain of needle at the time of
injection by the new surface anesthesia
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine | Maneuver |
Interventions/Control_1
Usage of the new surface anesthesia
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
The patient who will receive blood draw or infusion more than twice during observation period.
Key exclusion criteria
The patient who have allergy against lidocaine,
aminobenzoate or adrenalin.
The patient who have possibility of pregnancy or nursing.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Mishima Katsuaki |
Organization
Yamaguchi University Graduate School of Medicine
Division name
Department of Oral and Maxillofacial Surgery
Zip code
Address
1-1-1 Minamikogushi, Ube 755-8505, Japan
TEL
0836-22-2297
kmishima@yamaguchi-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Harada Koji |
Organization
Yamaguchi University Graduate School of Medicine
Division name
Department of Oral and Maxillofacial Surgery
Zip code
Address
1-1-1 Minamikogushi, Ube 755-8505, Japan
TEL
0836-22-2299
Homepage URL
harako@yamaguchi-u.ac.jp
Sponsor or person
Institute
Yamaguchi University
Institute
Department
Personal name
Funding Source
Organization
Yamaguchi University
Organization
Division
Category of Funding Organization
Government offices of other countries
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 01 | Month | 04 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2017 | Year | 12 | Month | 11 | Day |
Date of IRB
Anticipated trial start date
| 2018 | Year | 01 | Month | 04 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 12 | Month | 14 | Day |
Last modified on
| 2017 | Year | 12 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034712
